comparemela.com

Latest Breaking News On - சர்வதேச தேடல் அதிகாரம் - Page 1 : comparemela.com

Palatin Technologies Announces Filing of International Patent Application Claiming PL9643

Palatin Technologies Announces Filing of International Patent Application Claiming PL9643 Application Could Provide U.S. and International Patent Coverage for PL9643, Palatin s Lead Compound for Dry Eye Disease Phase 2/3 Clinical Trial Currently Planned for Mid-2021 News provided by Share this article Share this article CRANBURY, N.J., Feb. 10, 2021 /PRNewswire/  Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced the filing of an international patent application under the Patent Cooperation Treaty (PCT) directed to the composition of PL9643 and a related family of melanocortin agonist peptides. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.